Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
525 Leser
Artikel bewerten:
(2)

DirectTrust Announces Appointment of New Board Members, Reelection of Current Members to Governing Body

Finanznachrichten News

Newly elected officials to assist in guiding DirectTrust's mission of furthering trust in healthcare data exchange

WASHINGTON, D.C., 3683 / ACCESSWIRE / July 23, 2024 / DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare data exchange through standards, accreditation, and other services, today announced the election of two new members to its Board of Directors, as well as the reelection of three current board members. The organization also announced the appointment of two new officers within the board who will begin serving two-year terms. In addition to the board selections, DirectTrust's Electronic Healthcare Network Accreditation Commission (EHNAC), which governs the organization's accreditation and certification programs, added two new commissioners to its governing body. New board members set to serve three-year terms through June 2027 include:

  • Lisa Nelson, Senior Vice President, Enterprise Integrations, ADVault, Inc.

  • Brandon Neiswender, Vice President and Chief Strategy Officer, CRISP Shared Services

Returning board members elected to their second three-year term through June 2027 include:

  • Brian Handspicker, Managing Partner, PracticalMarkets, Inc.

  • Vince Albanese, Founder, Tag Design Agency LLC

  • Muhammad Chebli, Vice President, Solutions, NextGen Healthcare

Newly appointed officers who have begun serving two-year terms include:

  • Vice Chair - James Murray, MS, Vice President, Clinical Informatics and Interoperability, CVS Health

  • Treasurer - Vince Albanese, Founder, Tag Design Agency LLC

Members terming off the board include:

  • Julie Maas, Founder and CEO, EMR Direct

  • Adam Apatoff, Chief Legal Officer, Secure Exchange Solutions, a Centauri Health Solutions Company

"The richness of industry knowledge and innovation from new Board Members will play a critical role in building upon DirectTrust's vision of a trusted, connected world," said Katherine Lusk, MHSM, RHIA, FAHIMA, DirectTrust Board Chair and Vice President Strategic Partnerships, Texas Health Services Authority. "As a Board, we look forward to the freshness of new conversations, ideas and building upon our solid foundation. The vision, leadership and guidance of our board members terming off has provided the structure for success. A big thank you to those stepping up to serve and to those who have served us so well."

New EHNAC Commissioners, who began serving their three-year terms on July 1 and will continue through June 2027, include:

  • Jill DeGraff, SVP of Regulatory, b.well Connected Health

  • Monica Keeneth, VP, Security Governance, Risk and Compliance, Inovalon

"Adding the invaluable experience of two prominent and well-respected industry thought leaders to our Commission is vital as we continue to achieve our mission of ensuring the highest standards of patient data privacy, security, and integrity," said Lee Barrett, Commission Executive Director, DirectTrust. "Their guidance, along with that of their fellow commissioners, is essential in helping our industry achieve quality and trust in healthcare information exchange through the adoption and implementation of industry standards."

A volunteer position, DirectTrust's Board of Directors supports the work of the organization with mission-based leadership and strategic governance. Directors work with the executive leadership team on policy, strategy, industry relationships, technological advances, and the end-user experience, including consumers, families, payers, and healthcare providers.

For more information on the DirectTrust Board of Directors, visit our leadership page.

About DirectTrust®
DirectTrust® is a non-profit, vendor-neutral alliance dedicated to establishing trust in a connected world. The organization serves as a forum for a consensus-driven community focused on health communication, an American National Standards Institute (ANSI) standards development organization, an accreditation and certification body through EHNAC (the Electronic Healthcare Network Accreditation Commission), and a developer of trust frameworks and supportive services for secure information exchange like Direct Secure Messaging and trusted, compliant document submission.

The goal of DirectTrust is to develop, promote, and, as necessary, help enforce the rules and best practices necessary to maintain privacy, security, and trust for stakeholders across and beyond healthcare. In addition, DirectTrust is committed to fostering widespread public confidence in the interoperable exchange of health information while promoting quality service, innovation, cooperation, and open competition in healthcare. To learn more, visit: DirectTrust.org.

###

Press contact information:

Tom Testa
Anderson Interactive
tom@andersoni.com

SOURCE: DirectTrust



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.